Tysabri Drug Interactions: 232 Major, 138 Moderate
Tysabri (Natalizumab) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tysabri. Always confirm against the full prescribing information.
100 interactions
Abacavir
Natalizumab may increase the hepatotoxic activities of Abacavir.
Level 2 evidence
Abiraterone
Natalizumab may increase the hepatotoxic activities of Abiraterone.
Level 2 evidence
Acarbose
Natalizumab may increase the hepatotoxic activities of Acarbose.
Level 2 evidence
Acetaminophen
Natalizumab may increase the hepatotoxic activities of Acetaminophen.
Level 2 evidence
Acetazolamide
Natalizumab may increase the hepatotoxic activities of Acetazolamide.
Level 2 evidence
Acitretin
Natalizumab may increase the hepatotoxic activities of Acitretin.
Level 2 evidence
Albendazole
Natalizumab may increase the hepatotoxic activities of Albendazole.
Level 2 evidence
Allopurinol
Natalizumab may increase the hepatotoxic activities of Allopurinol.
Level 2 evidence
Aminosalicylic acid
Natalizumab may increase the hepatotoxic activities of Aminosalicylic acid.
Level 2 evidence
Amiodarone
Natalizumab may increase the hepatotoxic activities of Amiodarone.
Level 2 evidence
Anidulafungin
Natalizumab may increase the hepatotoxic activities of Anidulafungin.
Level 2 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Natalizumab.
Level 2 evidence
Enter your NPI to unlock 31 major interactions for Tysabri
Tysabri (Natalizumab) has 775 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Tysabri (Natalizumab) has 232 major, 138 moderate, and 405 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tysabri. Always confirm against the full prescribing information.